FDA Warns GSK Over Manufacturing Violations In UK
The U.S. Food and Drug Administration on Tuesday published a warning letter sent to a GlaxoSmithKline PLC unit for allegedly not doing enough to prevent microbial contamination of drugs manufactured at...To view the full article, register now.
Already a subscriber? Click here to view full article